According to recent estimates, international financing for health-related R&D exceeds $160 billion and includes a diversity of sources: 51 percent private for-profit, 41 percent public, and 8 percent private not-for-profit.
Senator Casey discusses the sources of funding for health-related research and development.
Share & report
More from Bob Casey
Mr. President, I am grateful to be here on the floor today and to join with our colleague from Oregon who has led this fight as the chairman of the Senate Finance Committee to bring us to this moment where we have the chance to vote on a…
That is why I am introducing the Capping Prescription Drug Costs Act with nine of my Senate colleagues.
I mentioned my legislation, Capping Prescription Drug Costs Act. Senator Warnock and I have introduced that together.
Thank you, Senator Casey, for organizing this hearing and for all you do to improve support for caregivers.
Other voices in this conversation
